Doctor’s Briefing Weekly Coronavirus Summary | Health
Physician Information Staff
Here’s what the editors of Physician’s Briefing have chosen as the most important COVID-19 developments for you and your practice for the week of February 28 to March 4, 2022. This roundup includes the latest research news from journal studies and other reliable sources that is most likely to affect clinical practice.
US Surgeon General investigates COVID-19 misinformation
FRIDAY, March 4, 2022 (HealthDay News) — A COVID-19 health misinformation investigation has been launched by U.S. Surgeon General Vivek Murthy, MD
NFL removes all COVID-19 restrictions
FRIDAY, March 4, 2022 (HealthDay News) — The National Football League’s COVID-19 protocols will be lifted immediately under an agreement reached between the league and its players’ association. The agreement makes the NFL one of the first major sports leagues to take such a step, CBS News reported.
People also read…
Molnupiravir for non-severe COVID-19 added to lifetime guideline
FRIDAY, March 4, 2022 (HealthDay News) — Molnupiravir is recommended for patients with non-severe COVID-19 who are at highest risk of hospitalization, according to updated living guidelines from the World Health Organization. health on drugs for COVID-19, published online in March 2 in The BMJ.
Lower vaccine efficacy for adolescents with predominant Omicron
THURSDAY, March 3, 2022 (HealthDay News) — For adolescents, BNT162b2 vaccine efficacy was lower against emergency room visits and emergency care associated with COVID-19 during omicron prevalence, study finds published in the March 1 advance publication issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
Pfizer-BioNTech Booster counterpart safe for teens
THURSDAY, March 3, 2022 (HealthDay News) — In adolescents ages 12 to 17, reactions to the homologous Pfizer-BioNTech booster vaccination occur with similar frequency as after receiving the second dose of vaccine, and they are usually mild to moderate in intensity, according to a study published in the March 1 advance publication issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
White House unveils new COVID-19 response strategy
THURSDAY, March 3, 2022 (HealthDay News) — Accelerated research into new vaccines that could be ready within 100 days of the emergence of a new variant is a key feature of a new COVID response strategy -19 released by the White House on Wednesday.
Many seniors still have not received care delayed by COVID-19
THURSDAY, March 3, 2022 (HealthDay News) — The pandemic has disrupted health care for about 30 percent of seniors, according to results from the University of Michigan’s latest national survey on healthy aging.
Subsequent vaccination reduces the risk of COVID-19 reinfection
THURSDAY, March 3, 2022 (HealthDay News) — For patients who have recovered from COVID-19, the risk of recurrent infection is reduced with receipt of at least one dose of the BNT162b2 vaccine, according to a study published online on February 16 in the New England Journal of Medicine.
The CDC estimates that COVID-19 infections in the United States are now close to 140 million
WEDNESDAY, March 2, 2022 (HealthDay News) — The United States has recorded about 140 million COVID-19 infections since the start of the pandemic, according to new data from the United States Centers for Disease Control and Prevention. This number is well above the 74.3 million confirmed cases of COVID-19 nationwide as of January 31.
Biden unveils new ‘Test to Treat’ plan as key part of new COVID-19 strategy
WEDNESDAY, March 2, 2022 (HealthDay News) — A new “test to treat” plan will be a key part of a revamped national strategy to get the country back to normal, President Joe Biden announced during his state of the art address. the Union on Tuesday evening.
Biden expands FEMA COVID-19 aid to states
WEDNESDAY, March 2, 2022 (HealthDay News) — The U.S. Federal Emergency Management Agency’s full coverage of COVID-19 emergency response costs for states, tribes, and territories has been extended once again and will now run until July 1, the White House said on Tuesday.
Profile of Newly Diagnosed Diabetes on Admission to COVID-19
WEDNESDAY, March 2, 2022 (HealthDay News) — Among patients hospitalized with COVID-19, those with newly diagnosed diabetes mellitus at the time of admission had lower readings for blood glucose parameters and higher levels of inflammatory markers than those with pre-existing diabetes, according to a study published online Feb. 4 in the Diary of Diabetes and its Complications.
Rare MIS-C in 12-20 year olds after COVID-19 vaccination
WEDNESDAY, March 2, 2022 (HealthDay News) — Multisystem inflammatory syndrome in children is rare after vaccination against severe acute respiratory syndrome coronavirus 2, especially in those without signs of SARS-CoV- infection. 2, according to a study published online February 22 in The Lancet Child and adolescent health.
Link between COVID-19 vaccination and sudden hearing loss explored
TUESDAY, March 1, 2022 (HealthDay News) — The possible association between COVID-19 vaccination and sudden sensorineural hearing loss is unclear, according to two studies published online Feb. JAMA Otorhinolaryngology – Head and Neck Surgery.
CPA issues final practice points for use of remdesivir in COVID-19
TUESDAY, March 1, 2022 (HealthDay News) — In a living systematic review and updated article published online March 1 in the Annals of Internal Medicinefinal practice points are presented for the use of remdesivir in hospitalized patients with COVID-19.
AAN: Severity of tics in teens linked to social media use during pandemic
TUESDAY, March 1, 2022 (HealthDay News) — Increased use of social media during the COVID-19 pandemic is correlated with increased severity of tics and reduced quality of life among adolescents with tics, according to a study whose the presentation is scheduled for the upcoming annual meeting of the American Academy of Neurology, to be held April 2-7 in Seattle.
Risk of progression to severe COVID-19 reduced with nirmatrelvir + ritonavir
TUESDAY, March 1, 2022 (HealthDay News) — For patients with symptomatic COVID-19, treatment with nirmatrelvir plus ritonavir reduces the risk of progression to severe COVID-19, according to a study published online February 16 in the New England Journal of Medicine.
Vaccination boosts acquired immunity against SARS-CoV-2
TUESDAY, March 1, 2022 (HealthDay News) — Two doses of BNT162b2 vaccine are associated with high short-term protection against severe acute respiratory syndrome coronavirus 2 infection, which wanes after six months, while immunity remains high for people with an acquired infection. immunity boosted by vaccination, according to a study published online February 16 in the New England Journal of Medicine.
Nearly half of the 500 million free COVID-19 tests remain
MONDAY, Feb. 28, 2022 (HealthDay News) — As COVID-19 cases dwindle in the United States, nearly half of the 500 million free tests offered by the federal government have gone unused, according to the White House.
Systemic cancer therapy not linked to higher mortality from COVID-19
MONDAY, Feb. 28, 2022 (HealthDay News) — According to a study published online Feb. 21 in Open JAMA Network.
Asymptomatic SARS-CoV-2 infection appears to be less common
MONDAY, Feb. 28, 2022 (HealthDay News) — Completely asymptomatic severe acute respiratory syndrome coronavirus-2 infection appears to be less common than reported, according to a study published online Feb. 14 in Open Forum on Infectious Diseases.
Children and adults can transmit SARS-CoV-2 to household contacts
MONDAY, Feb. 28, 2022 (HealthDay News) — Children and adults in a household can transmit and are susceptible to severe acute respiratory syndrome coronavirus 2 infection, according to a study published online Feb. 23 in Pediatrics.
Vaccine rollout linked to decline in severe COVID-19 in dialysis patients
MONDAY, Feb. 28, 2022 (HealthDay News) — The incidence of serious COVID-19 infections has been lower than expected in dialysis patients since the vaccine began to be rolled out; and SARS-CoV-2 spike protein antibody titers decline significantly within six months of COVID-19 vaccination in patients on maintenance dialysis, according to two studies published online February 10 in the Clinical Journal of the American Society of Nephrology.
Improved External Counterpulsation Eases “Long COVID”
MONDAY, Feb. 28, 2022 (HealthDay News) — For patients with “long COVID”, improved external counterpulsation therapy is associated with improved symptoms, including fatigue and difficulty breathing, according to a study presented at the American College of Cardiology virtual Cardiovascular Summit, held February 16-19.
This article was originally published on consumer.healthday.com.